<code id='05603EC737'></code><style id='05603EC737'></style>
    • <acronym id='05603EC737'></acronym>
      <center id='05603EC737'><center id='05603EC737'><tfoot id='05603EC737'></tfoot></center><abbr id='05603EC737'><dir id='05603EC737'><tfoot id='05603EC737'></tfoot><noframes id='05603EC737'>

    • <optgroup id='05603EC737'><strike id='05603EC737'><sup id='05603EC737'></sup></strike><code id='05603EC737'></code></optgroup>
        1. <b id='05603EC737'><label id='05603EC737'><select id='05603EC737'><dt id='05603EC737'><span id='05603EC737'></span></dt></select></label></b><u id='05603EC737'></u>
          <i id='05603EC737'><strike id='05603EC737'><tt id='05603EC737'><pre id='05603EC737'></pre></tt></strike></i>

          leisure time

          leisure time

          author:comprehensive    Page View:878
          Elizabeth Warren speaks behind a podium with a sign that reads "ABORTION RIGHTS FOR ALL"
          Sen. Elizabeth Warren (D-Mass.) J. Scott Applewhite/AP

          WASHINGTON — Sen. Elizabeth Warren (D-Mass.) is launching a fresh round of questioning on states’ limits to abortion rights as a battle on medication abortion hangs in the balance at a federal court.

          Warren and three other Democratic senators sent letters late last week to five major health care worker and pharmacy groups interrogating how last year’s U.S. Supreme Court decision reversing national abortion rights has affected health care access and providers’ treatment of patients.

          advertisement

          It’s not the first time the Massachusetts Democrat has aimed questions at these organizations, which include the American Medical Association, Physicians for Reproductive Health, National Nurses United, the American Pharmacists Association, and the American Hospital Association. She asked the same set of groups last summer how the U.S. Supreme Court’s overturn of Roe v. Wade impacted women’s health care, and reported in October that the groups warned about “diminished access” to pregnancy care and abortion bans that “will exacerbate existing health inequities.”

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Travis Kelce and the trap of celebrity vaccine endorsements
          Travis Kelce and the trap of celebrity vaccine endorsements

          Illustration:STAT;ScreencaptureOncethedomainofagingTVstars,hawkinghealthproductsfromvitaminstodiabet

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Gene therapy’s promise and the high cost of hope

          AdobeAtthebustlingChicagoO’Hareairport,myluggageandIcollidedwithanelderlycouple.MyheartsankwhenIreal